Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cognitive Dysfunction × Ramipril × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hypertension 1 Glioblastoma 1 Cognitive Dysfunction 1 Brain Neoplasms 1

Interventions

Memantine 2 acetaminophen, aspirin, caffeine drug combination 1 Transcranial Direct Current Stimulation 1 Time 1 Sugars 1 Sirolimus 1 Riluzole 1 Ramipril 1 Radiotherapy, Intensity-Modulated 1 Palliative Care 1 Ibuprofen 1 Exercise 1 Donepezil 1 Cognitive Behavioral Therapy 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed

75 enrolled 47 charts

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡